Stay updated on Upadacitinib vs Abatacept in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Abatacept in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Abatacept in RA Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check21 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.8%
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page has removed a citation regarding patient-reported outcomes of upadacitinib versus abatacept in rheumatoid arthritis, including an erratum reference.SummaryDifference0.2%
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check64 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study objectives and criteria for a clinical trial on rheumatoid arthritis, while adding a new revision number and an EudraCT number.SummaryDifference12%
- Check71 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to Upadacitinib vs Abatacept in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Abatacept in RA Clinical Trial page.